fotaxime, ceftizoxime, cefoperazone, ceftazidime, ceftriaxone, moxalactam, and imipenem/cilastatin compared with 1st and 2nd generation agents, these drugs have expanded gram negative coverage, and some are able to cross the blood-brain barrier